Suppr超能文献

肝硬化患者对标准蛋白质餐和高蛋白餐的蛋白质耐受性

Protein tolerance to standard and high protein meals in patients with liver cirrhosis.

作者信息

Campollo Octavio, Sprengers Dirk, Dam Gitte, Vilstrup Hendrik, McIntyre Neil

机构信息

Octavio Campollo, Center of Studies on Alcohol and Addictions, Antigüo Hospital Civil de Guadalajara, Universidad de Guadalajara, Guadalajara, Jal CP 44280, Mexico.

出版信息

World J Hepatol. 2017 May 18;9(14):667-676. doi: 10.4254/wjh.v9.i14.667.

Abstract

AIM

To investigate the plasma amino acid response and tolerance to normal or high protein meals in patients with cirrhosis.

METHODS

The plasma amino acid response to a 20 g mixed protein meal was compared in 8 biopsy-proven compensated cirrhotic patients and 6 healthy subjects. In addition the response to a high protein meal (1 g/kg body weight) was studied in 6 decompensated biopsy-proven cirrhotics in order to evaluate their protein tolerance and the likelihood of developing hepatic encephalopathy (HE) following a porto-caval shunt procedure. To test for covert HE, the "number connection test" (NCT) was done on all patients, and an electroencephalogram was recorded in patients considered to be at Child-Pugh C stage.

RESULTS

The changes in plasma amino acids after a 20 g protein meal were similar in healthy subjects and in cirrhotics except for a significantly greater increase ( < 0.05) in isoleucine, leucine and tyrosine concentrations in the cirrhotics. The baseline branched chain amino acids/aromatic amino acids (BCAA/AAA) ratio was higher in the healthy persons and remained stable-but it decreased significantly after the meal in the cirrhotic group. After the high protein meal there was a marked increase in the levels of most amino acids, but only small changes occurred in the levels of taurine, citrulline, cysteine and histidine.The BCAA/AAA ratio was significantly higher 180 and 240 min after the meal. Slightly elevated basal plasma ammonia levels showed no particular pattern. Overt HE was not observed in any patients.

CONCLUSION

Patients with stable liver disease tolerate natural mixed meals with a standard protein content. The response to a high protein meal in decompensated cirrhotics suggests accumulation of some amino acids but it did not precipitate HE. These results support current nutritional guidelines that recommend a protein intake of 1.2-1.5 g/kg body weight/day for patients with cirrhosis.

摘要

目的

研究肝硬化患者血浆氨基酸对正常或高蛋白膳食的反应及耐受性。

方法

比较8例经活检证实的代偿期肝硬化患者和6名健康受试者对20克混合蛋白膳食的血浆氨基酸反应。此外,对6例经活检证实的失代偿期肝硬化患者进行高蛋白膳食(1克/千克体重)反应研究,以评估其蛋白质耐受性及门腔分流术后发生肝性脑病(HE)的可能性。为检测隐匿性HE,对所有患者进行“数字连接试验”(NCT),并对处于Child-Pugh C级的患者进行脑电图记录。

结果

健康受试者和肝硬化患者在摄入20克蛋白质膳食后血浆氨基酸变化相似,但肝硬化患者异亮氨酸、亮氨酸和酪氨酸浓度显著升高(<0.05)。健康人基线支链氨基酸/芳香族氨基酸(BCAA/AAA)比值较高且保持稳定,但肝硬化组在进食后该比值显著下降。高蛋白膳食后大多数氨基酸水平显著升高,但牛磺酸、瓜氨酸、半胱氨酸和组氨酸水平变化较小。进食后180分钟和240分钟时BCAA/AAA比值显著升高。基础血浆氨水平略有升高但无特定模式。所有患者均未观察到明显的HE。

结论

肝病稳定的患者能耐受标准蛋白质含量的天然混合膳食。失代偿期肝硬化患者对高蛋白膳食的反应表明某些氨基酸会蓄积,但未引发HE。这些结果支持当前营养指南,即建议肝硬化患者蛋白质摄入量为1.2 - 1.5克/千克体重/天。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/5437611/e8f2b14f7cba/WJH-9-667-g001.jpg

相似文献

1
Protein tolerance to standard and high protein meals in patients with liver cirrhosis.
World J Hepatol. 2017 May 18;9(14):667-676. doi: 10.4254/wjh.v9.i14.667.
2
Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.
J Gastroenterol Hepatol. 2007 Aug;22(8):1241-8. doi: 10.1111/j.1440-1746.2006.04620.x.
3
Dynamic Elevation of Aromatic Amino Acids in Hepatitis C Virus-Induced Cirrhosis After a Standard Meal.
Clin Transl Gastroenterol. 2024 Mar 1;15(3):e00666. doi: 10.14309/ctg.0000000000000666.
6
Muscle metabolism and whole blood amino acid profile in patients with liver disease.
Scand J Clin Lab Invest. 2015;75(8):674-80. Epub 2015 Aug 4.
7
Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
Nutrition. 2015 Jan;31(1):14-20. doi: 10.1016/j.nut.2014.03.016. Epub 2014 Mar 30.
8
Aromatic amino acid metabolism during liver failure.
J Nutr. 2007 Jun;137(6 Suppl 1):1579S-1585S; discussion 1597S-1598S. doi: 10.1093/jn/137.6.1579S.
9
The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy.
J Clin Exp Hepatol. 2018 Dec;8(4):448-451. doi: 10.1016/j.jceh.2018.06.004. Epub 2018 Jun 27.

引用本文的文献

1
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.
Am J Gastroenterol. 2025 May 1;120(5):950-972. doi: 10.14309/ajg.0000000000003379. Epub 2025 May 2.
3
Nutritional Support for Alcoholic Liver Disease.
Nutrients. 2023 Mar 10;15(6):1360. doi: 10.3390/nu15061360.
4
The Link between Gut Microbiota and Hepatic Encephalopathy.
Int J Mol Sci. 2022 Aug 12;23(16):8999. doi: 10.3390/ijms23168999.
6
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):97-143. doi: 10.1016/j.jceh.2020.09.003. Epub 2020 Oct 1.
7
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.
World J Hepatol. 2019 Jun 27;11(6):489-512. doi: 10.4254/wjh.v11.i6.489.
9
Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration.
J Clin Exp Hepatol. 2019 Jan-Feb;9(1):125-130. doi: 10.1016/j.jceh.2018.04.007. Epub 2018 May 5.
10
Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis.
Int J Exp Pathol. 2018 Dec;99(6):274-281. doi: 10.1111/iep.12299. Epub 2019 Jan 13.

本文引用的文献

1
Branched-chain amino acids for people with hepatic encephalopathy.
Cochrane Database Syst Rev. 2015 Sep 17(9):CD001939. doi: 10.1002/14651858.CD001939.pub3.
2
Muscle metabolism and whole blood amino acid profile in patients with liver disease.
Scand J Clin Lab Invest. 2015;75(8):674-80. Epub 2015 Aug 4.
3
Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease: Overview of available evidence and open issues.
Dig Liver Dis. 2015 Oct;47(10):819-25. doi: 10.1016/j.dld.2015.05.021. Epub 2015 Jun 8.
5
Treatment to improve nutrition and functional capacity evaluation in liver transplant candidates.
Curr Treat Options Gastroenterol. 2014 Jun;12(2):242-55. doi: 10.1007/s11938-014-0016-9.
6
Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
Clin Gastroenterol Hepatol. 2014 Jun;12(6):1012-8.e1. doi: 10.1016/j.cgh.2013.08.050. Epub 2013 Sep 10.
10
Restricting protein intake not beneficial.
Dtsch Arztebl Int. 2012 Jul;109(29-30):502; author reply 502-3. doi: 10.3238/arztebl.2012.0502a. Epub 2012 Jul 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验